

Vincerx Pharma announces early results for VIP943 and VIP236 in Phase 1 studies targeting hard-to-treat cancers, with complete responses seen in AML and HR-MDS...
You can purchase shares of VINCERX PHARMA INC by Vincerx Pharma, Inc. (OTCEM:VINC) through any online brokerage.
There are no as such competitors for VINCERX PHARMA INC by Vincerx Pharma, Inc..
VINCERX PHARMA INC by Vincerx Pharma, Inc. has a consensus price target of $40.00.
The stock price for VINCERX PHARMA INC by Vincerx Pharma, Inc. (OTCEM: VINC) is $0.016 last updated November 18, 2026 at 2:09 PM EST.
There are no upcoming dividends for VINCERX PHARMA INC by Vincerx Pharma, Inc..
VINCERX PHARMA INC by Vincerx Pharma, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for VINCERX PHARMA INC by Vincerx Pharma, Inc..
VINCERX PHARMA INC by Vincerx Pharma, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.
Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the...